Sen. Ed Markey, D-Massachusetts, has sent letters to CEOs of at-home COVID-19 test-makers, asking why tests are selling for as much as $12 apiece. In a letter sent today to Abbott CEO Robert Ford, for example, Markey cited a Reuters story from October 2021 in which British test-maker Mologic said that rapid antigen tests can […]
Abbott (NYSE:ABT) was among a series of medtech companies to receive recognition from Time in its list of 2021’s best inventions. The list of the year’s top inventions included Abbott’s innovations twice, with a nod to its NeuroSphere Virtual Clinic and its at-home COVID-19 testing offerings. Get the full story at our sister site, Medical Design & Outsourcing.
The FDA today announced that it issued emergency use authorization (EUA) for Acon Laboratories’ Flowflex COVID-19 home test. Authorization of the antigen test should significantly increase the availability of rapid, at-home tests, director of FDA’s Center for Devices and Radiological Health Dr. Jeff Shuren said in a statement. The agency expects fast, at-home testing capacity […]